The COVID-19 pandemic has reminded us of how important the life science industry is, and compels us to find efficient management methods specific to the industry. Pharmaceuticals, drug and vaccine development labs, R&D labs, medical instrumentation, and tech companies, hygiene supply companies, medical distribution chains, all form an integral part of this industry. At the interface of scientific research, technology, innovation and management and embedded in regulatory and legal frameworks, life science management is still an under-researched field of practice and science. This edited volume addresses this research gap and offers a wide range of practical and theoretical contributions that provide insights into one of the most exciting industries. The book is primarily directed at practitioners and decision makers in the life science industry. Students and professionals of life science management at all levels as well as policy makers will find valuable insights and inspiration for their daily work and career development.

The healthcare professionals who save and extend our lives are helpless without the medicines and technologies that have revolutionised medical care. But the industry that invents, makes and provides these indispensable tools is transforming under the pressure of ageing populations, globalisation and revolutions in biological and information technology. How this industry adapts and evolves is vitally important to every one of us. This book looks inside the heads and hearts of the people who lead the global pharmaceutical and medical technology industry. It describes how they make sense of their markets and the wider life sciences economy. It reveals what they have learned about how to lead large, complex organisations to compete in dynamic, global markets. Leadership in the Life Sciences is essential reading for anyone working in or with the pharmaceutical and medical technology industry and its halo of supporting companies. Written as ten succinct lessons, it gives the reader unique insight into what the industry’s leaders are thinking. Covering topics from leadership to organisational culture, from change management to digital disruption and from competitive strategy to value-creation, each chapter distils the accumulated wisdom of those who lead the complex and turbulent life sciences industry.

Make healthcare analytics work: leverage its powerful opportunities for improving outcomes, cost, and efficiency.This book gives you thepractical frameworks, strategies, tactics, and case studies you need to go beyond talk to action. The contributing healthcare analytics innovators survey the field's current state, present start-to-finish guidance for planning and implementation, and help decision-makers prepare for tomorrow's advances. They present in-depth case studies revealing how leading organizations have organized and executed analytic strategies that work, and fully cover the primary applications of analytics in all three sectors of the healthcare ecosystem: Provider, Payer, and Life Sciences. Co-published with the International Institute for Analytics (IIA), this book features the combined expertise of IIA's team of leading health analytics practitioners and researchers. Each chapter is written by a member of the IIA faculty, and bridges the latest research findings with proven best practices. This book will be valuable to professionals and decision-makers throughout the healthcare ecosystem, including provider organization clinicians and managers; life sciences researchers and practitioners; and informaticists, actuaries, and managers at payer organizations. It will also be valuable in diverse analytics, operations, and IT courses in business, engineering, and healthcare certificate programs.

Addresses in roughly equal measure the science and management behind several recent marketable biomedical innovations.

Connect students in grades 6–8 with science using Life Science Quest for Middle Grades. This 96-page book helps students practice scientific techniques while studying cells, plants, animals, DNA, heredity, ecosystems, and biomes. The activities use common classroom materials and are perfect for individual, team, and whole-group projects. The book includes a glossary, standards lists, unit overviews, and enrichment suggestions. It is great as core curriculum or a supplement and supports National Science Education Standards.

The global center of gravity in life sciences innovation is rapidly shifting to emerging economies. In The New Players in Life Science Innovation, Tomasz Mroczkowski explains how China and other new economic powers are rapidly gaining leadership positions, and thoroughly assesses the implications. Mroczkowski discusses the sophisticated innovation strategies and reforms these nations have implemented: approaches that don't rely on market forces alone, and are achieving remarkable success. Next, he previews the emerging global "bio-economy," in which life science discoveries will be applied pervasively in markets ranging from health to fuels. As R&D in the West becomes increasingly costly, Mroczkowski introduces new options for partnering with new players in the field. He thoroughly covers the globalization of clinical trials, showing how it offers opportunities that go far beyond cost reduction, and assessing the unique challenges it presents. Offering examples from China to Dubai to India, he carefully assesses the business models driving today's newest centers of innovation. Readers will find up-to-date coverage of bioparks, technology zones, and emerging clusters, and realistic assessments of global R&D collaboration strategies such as those of Eli Lilly, Merck, Novartis, and IBM. With innovation-driven industries increasingly dominating the global economy, this book's insights are indispensable for every R&D decision-maker and investor.

The potential misuse of advances in life sciences research is raising concerns about national security threats. Dual Use Research of Concern in the Life Sciences: Current Issues and Controversies examines the U.S. strategy for reducing biosecurity risks in life sciences research and considers mechanisms that would allow researchers to manage the dissemination of the results of research while mitigating the potential for harm to national security.